10.25.2016

Convergex Signs Exclusive License Agreement For The OptionEyes To Assist Traders With Risk and Portfolio Management

10.25.2016

Convergex – New York, NY  – Convergex, an agency‐based global brokerage and trading related  services provider, is pleased to announce that it has entered into an agreement granting it an exclusive  license to The OptionEyes, a front‐end technology platform that helps active traders manage and trade  positions in an options or equity portfolio.

The OptionEyes uses enhanced OMS technology and provides clients with flexibility in how they trade,  view, and manage risk in their equity and options portfolios.  Additional functionality of The OptionEyes  platform includes:  

Scanners to allow traders to pre‐set or create strategies that will trade automatically or send an  alert when opportunities appear in the marketplace;

Simple “click‐through” work flow process for generating complex and single‐leg orders;  

An enhanced volatility management infrastructure.

“Convergex is excited to offer a new set of functionality and technology to our clients,” said Ben  Londergan, Convergex Executive Managing Director of Options Trading and Technology.  “This new  software will allow Convergex to add value to both active retail and institutional clients as well as other  market participants responsible for managing large portfolios of positions and who want to employ a  more streamlined approach to their trading and risk management,” said Londergan.

Members of the development team who created The OptionEyes will join Convergex’s options team and  Convergex anticipates the platform will be fully integrated by January 2017.

Related articles

  1. The exchange will use a price time-model and is expected to launch in early 2023.

  2. The firm's Pearl Equities exchange executed 2.4 billion shares in June.

  3. Aim is to help investors better navigate the characteristics and risks of standardized options.

  4. Trading Europe From ‘Across the Pond’

    Status grants clearing members clarity on the regulatory treatment of their exposures to OCC.

  5. Volatility Back 'With a Vengeance'

    In May CME Ether futures had the highest volumes since launch.